[1] 中华医学会心血管病学分会,中国心肌炎心肌病协作组.中国扩张型心肌病诊断和治疗指南[J]. 临床心血管病杂志, 2018, 34(5): 421-34. [2] 郭晓辰,张军平,朱亚萍, 等. 病毒性心肌炎患者临床转归及预后因素的随访研究[J]. 中华中医药杂志, 2014, 29(5): 1626-1629. [3] 吴可贵. 病例101:高血压与心脏扩大[J].中华高血压杂志, 2010, 18(10): 991-995. [4] Suematsu Y, Miura S, Goto M, et al.LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice[J]. Eur J Heart Fail, 2016, 18(4): 386-393. [5] Guo L Y, Liu B, Sun Z C, et al.Miraculous Recovery of a Dilated Heart after Usage of Supramaximal Titrated Valsartan for 8 Months[J]. Chin Med J (Engl). 2016, 129(22): 2771-2772. [6] Almufleh A, Marbach J, Chih S, et al.Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients[J]. Am J Cardiovasc Dis, 2017, 7(6): 108-113. |